Selected research
Market Structure
Global EPA and DHA Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global EPA and DHA Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of EPA and DHA Formula include Doctor's Nutrition, Efamol, Jarrow Formulas, Lepivits, Metagenics, Nature's Way Products, Now, Perelel and Puori, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global EPA and DHA Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of EPA and DHA Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents EPA and DHA Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA and DHA Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
EPA and DHA Formula Segment by Company
Doctor's Nutrition
Efamol
Jarrow Formulas
Lepivits
Metagenics
Nature's Way Products
Now
Perelel
Puori
Ross J. Barr
Thorne
Youtheory
EPA and DHA Formula Segment by Type
From Plants
From Animals
EPA and DHA Formula Segment by Application
Online Sales
Offline Sales
EPA and DHA Formula Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the EPA and DHA Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EPA and DHA Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of EPA and DHA Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of EPA and DHA Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- From Plants
- From Animals
Applications
- Online Sales
- Offline Sales
Companies covered
- Doctor's Nutrition
- Efamol
- Jarrow Formulas
- Lepivits
- Metagenics
- Nature's Way Products
- Now
- Perelel
- Puori
- Ross J. Barr
- Thorne
- Youtheory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global EPA and DHA Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global EPA and DHA Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global EPA and DHA Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global EPA and DHA Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global EPA and DHA Formula Market Dynamics
- 2.1 EPA and DHA Formula Industry Trends
- 2.2 EPA and DHA Formula Industry Drivers
- 2.3 EPA and DHA Formula Industry Opportunities and Challenges
- 2.4 EPA and DHA Formula Industry Restraints
3 EPA and DHA Formula Market by Manufacturers
- 3.1 Global EPA and DHA Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global EPA and DHA Formula Sales by Manufacturers (2021-2026)
- 3.3 Global EPA and DHA Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global EPA and DHA Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global EPA and DHA Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global EPA and DHA Formula Manufacturers, Product Type & Application
- 3.7 Global EPA and DHA Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global EPA and DHA Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 EPA and DHA Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 EPA and DHA Formula Tier 1, Tier 2, and Tier 3
4 EPA and DHA Formula Market by Type
- 4.1 EPA and DHA Formula Type Introduction
- 4.1.1 From Plants
- 4.1.2 From Animals
- 4.2 Global EPA and DHA Formula Sales by Type
- 4.2.1 Global EPA and DHA Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global EPA and DHA Formula Sales by Type (2021-2032)
- 4.2.3 Global EPA and DHA Formula Sales Market Share by Type (2021-2032)
- 4.3 Global EPA and DHA Formula Revenue by Type
- 4.3.1 Global EPA and DHA Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global EPA and DHA Formula Revenue by Type (2021-2032)
- 4.3.3 Global EPA and DHA Formula Revenue Market Share by Type (2021-2032)
5 EPA and DHA Formula Market by Application
- 5.1 EPA and DHA Formula Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global EPA and DHA Formula Sales by Application
- 5.2.1 Global EPA and DHA Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global EPA and DHA Formula Sales by Application (2021-2032)
- 5.2.3 Global EPA and DHA Formula Sales Market Share by Application (2021-2032)
- 5.3 Global EPA and DHA Formula Revenue by Application
- 5.3.1 Global EPA and DHA Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global EPA and DHA Formula Revenue by Application (2021-2032)
- 5.3.3 Global EPA and DHA Formula Revenue Market Share by Application (2021-2032)
6 Global EPA and DHA Formula Sales by Region
- 6.1 Global EPA and DHA Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global EPA and DHA Formula Sales by Region (2021-2032)
- 6.2.1 Global EPA and DHA Formula Sales by Region (2021-2026)
- 6.2.2 Global EPA and DHA Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America EPA and DHA Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America EPA and DHA Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe EPA and DHA Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe EPA and DHA Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific EPA and DHA Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific EPA and DHA Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa EPA and DHA Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa EPA and DHA Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global EPA and DHA Formula Revenue by Region
- 7.1 Global EPA and DHA Formula Revenue by Region
- 7.1.1 Global EPA and DHA Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global EPA and DHA Formula Revenue by Region (2021-2026)
- 7.1.3 Global EPA and DHA Formula Revenue by Region (2027-2032)
- 7.1.4 Global EPA and DHA Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America EPA and DHA Formula Revenue (2021-2032)
- 7.2.2 North America EPA and DHA Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe EPA and DHA Formula Revenue (2021-2032)
- 7.3.2 Europe EPA and DHA Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific EPA and DHA Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific EPA and DHA Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa EPA and DHA Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa EPA and DHA Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Doctor's Nutrition
- 8.1.1 Doctor's Nutrition Company Information
- 8.1.2 Doctor's Nutrition Business Overview
- 8.1.3 Doctor's Nutrition EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Doctor's Nutrition EPA and DHA Formula Product Portfolio
- 8.1.5 Doctor's Nutrition Recent Developments
- 8.2 Efamol
- 8.2.1 Efamol Company Information
- 8.2.2 Efamol Business Overview
- 8.2.3 Efamol EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Efamol EPA and DHA Formula Product Portfolio
- 8.2.5 Efamol Recent Developments
- 8.3 Jarrow Formulas
- 8.3.1 Jarrow Formulas Company Information
- 8.3.2 Jarrow Formulas Business Overview
- 8.3.3 Jarrow Formulas EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jarrow Formulas EPA and DHA Formula Product Portfolio
- 8.3.5 Jarrow Formulas Recent Developments
- 8.4 Lepivits
- 8.4.1 Lepivits Company Information
- 8.4.2 Lepivits Business Overview
- 8.4.3 Lepivits EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lepivits EPA and DHA Formula Product Portfolio
- 8.4.5 Lepivits Recent Developments
- 8.5 Metagenics
- 8.5.1 Metagenics Company Information
- 8.5.2 Metagenics Business Overview
- 8.5.3 Metagenics EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Metagenics EPA and DHA Formula Product Portfolio
- 8.5.5 Metagenics Recent Developments
- 8.6 Nature's Way Products
- 8.6.1 Nature's Way Products Company Information
- 8.6.2 Nature's Way Products Business Overview
- 8.6.3 Nature's Way Products EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nature's Way Products EPA and DHA Formula Product Portfolio
- 8.6.5 Nature's Way Products Recent Developments
- 8.7 Now
- 8.7.1 Now Company Information
- 8.7.2 Now Business Overview
- 8.7.3 Now EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Now EPA and DHA Formula Product Portfolio
- 8.7.5 Now Recent Developments
- 8.8 Perelel
- 8.8.1 Perelel Company Information
- 8.8.2 Perelel Business Overview
- 8.8.3 Perelel EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Perelel EPA and DHA Formula Product Portfolio
- 8.8.5 Perelel Recent Developments
- 8.9 Puori
- 8.9.1 Puori Company Information
- 8.9.2 Puori Business Overview
- 8.9.3 Puori EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Puori EPA and DHA Formula Product Portfolio
- 8.9.5 Puori Recent Developments
- 8.10 Ross J. Barr
- 8.10.1 Ross J. Barr Company Information
- 8.10.2 Ross J. Barr Business Overview
- 8.10.3 Ross J. Barr EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Ross J. Barr EPA and DHA Formula Product Portfolio
- 8.10.5 Ross J. Barr Recent Developments
- 8.11 Thorne
- 8.11.1 Thorne Company Information
- 8.11.2 Thorne Business Overview
- 8.11.3 Thorne EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Thorne EPA and DHA Formula Product Portfolio
- 8.11.5 Thorne Recent Developments
- 8.12 Youtheory
- 8.12.1 Youtheory Company Information
- 8.12.2 Youtheory Business Overview
- 8.12.3 Youtheory EPA and DHA Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Youtheory EPA and DHA Formula Product Portfolio
- 8.12.5 Youtheory Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 EPA and DHA Formula Value Chain Analysis
- 9.1.1 EPA and DHA Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 EPA and DHA Formula Production Mode & Process
- 9.2 EPA and DHA Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 EPA and DHA Formula Distributors
- 9.2.3 EPA and DHA Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst